The World Health Organization (WHO) has granted Emergency Use Listing (EUL) for the LC16m8 mpox vaccine, making it the second mpox vaccine to be supported by WHO following the Director-General's ...

Barriers to widespread access to cancer treatments include excessive cost and lack of affordability, according to a review ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

A new study published in the Journal of Clinical Investigation found that COVID was linked to cancer regression, which could ...

In a breakthrough development, scientists from the US have found that cells activated by severe COVID-19 infection can be ...

A small trial of an experimental vaccine has shown promising results for patients with the most aggressive type of breast ...